383 related articles for article (PubMed ID: 12118074)
21. The p38 MAPK inhibitor, PD169316, inhibits transforming growth factor beta-induced Smad signaling in human ovarian cancer cells.
Fu Y; O'Connor LM; Shepherd TG; Nachtigal MW
Biochem Biophys Res Commun; 2003 Oct; 310(2):391-7. PubMed ID: 14521923
[TBL] [Abstract][Full Text] [Related]
22. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.
Janda E; Lehmann K; Killisch I; Jechlinger M; Herzig M; Downward J; Beug H; Grünert S
J Cell Biol; 2002 Jan; 156(2):299-313. PubMed ID: 11790801
[TBL] [Abstract][Full Text] [Related]
23. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration.
Bakin AV; Tomlinson AK; Bhowmick NA; Moses HL; Arteaga CL
J Biol Chem; 2000 Nov; 275(47):36803-10. PubMed ID: 10969078
[TBL] [Abstract][Full Text] [Related]
24. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cells.
Wang L; Ma R; Flavell RA; Choi ME
J Biol Chem; 2002 Dec; 277(49):47257-62. PubMed ID: 12374793
[TBL] [Abstract][Full Text] [Related]
25. Efficient TGFβ-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2.
Porsch H; Bernert B; Mehić M; Theocharis AD; Heldin CH; Heldin P
Oncogene; 2013 Sep; 32(37):4355-65. PubMed ID: 23108409
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA.
Edlund S; Landström M; Heldin CH; Aspenström P
Mol Biol Cell; 2002 Mar; 13(3):902-14. PubMed ID: 11907271
[TBL] [Abstract][Full Text] [Related]
27. Epithelial-mesenchymal transformation in the embryonic heart is mediated through distinct pertussis toxin-sensitive and TGFbeta signal transduction mechanisms.
Boyer AS; Erickson CP; Runyan RB
Dev Dyn; 1999 Jan; 214(1):81-91. PubMed ID: 9915578
[TBL] [Abstract][Full Text] [Related]
28. Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor beta induced epithelial to mesenchymal transition.
Andarawewa KL; Erickson AC; Chou WS; Costes SV; Gascard P; Mott JD; Bissell MJ; Barcellos-Hoff MH
Cancer Res; 2007 Sep; 67(18):8662-70. PubMed ID: 17875706
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.
Ueda Y; Wang S; Dumont N; Yi JY; Koh Y; Arteaga CL
J Biol Chem; 2004 Jun; 279(23):24505-13. PubMed ID: 15044465
[TBL] [Abstract][Full Text] [Related]
30. TbetaRI/Alk5-independent TbetaRII signaling to ERK1/2 in human skin cells according to distinct levels of TbetaRII expression.
Bandyopadhyay B; Han A; Dai J; Fan J; Li Y; Chen M; Woodley DT; Li W
J Cell Sci; 2011 Jan; 124(Pt 1):19-24. PubMed ID: 21172820
[TBL] [Abstract][Full Text] [Related]
31. Regulation of biglycan gene expression by transforming growth factor-beta requires MKK6-p38 mitogen-activated protein Kinase signaling downstream of Smad signaling.
Ungefroren H; Lenschow W; Chen WB; Faendrich F; Kalthoff H
J Biol Chem; 2003 Mar; 278(13):11041-9. PubMed ID: 12538652
[TBL] [Abstract][Full Text] [Related]
32. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.
Piek E; Moustakas A; Kurisaki A; Heldin CH; ten Dijke P
J Cell Sci; 1999 Dec; 112 ( Pt 24)():4557-68. PubMed ID: 10574705
[TBL] [Abstract][Full Text] [Related]
33. Enamel matrix derivative (EMDOGAIN) rapidly stimulates phosphorylation of the MAP kinase family and nuclear accumulation of smad2 in both oral epithelial and fibroblastic human cells.
Kawase T; Okuda K; Momose M; Kato Y; Yoshie H; Burns DM
J Periodontal Res; 2001 Dec; 36(6):367-76. PubMed ID: 11762872
[TBL] [Abstract][Full Text] [Related]
34. Selective inhibitors of type I receptor kinase block cellular transforming growth factor-beta signaling.
Ge R; Rajeev V; Subramanian G; Reiss KA; Liu D; Higgins L; Joly A; Dugar S; Chakravarty J; Henson M; McEnroe G; Schreiner G; Reiss M
Biochem Pharmacol; 2004 Jul; 68(1):41-50. PubMed ID: 15183116
[TBL] [Abstract][Full Text] [Related]
35. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway.
Yue J; Mulder KM
J Biol Chem; 2000 Oct; 275(40):30765-73. PubMed ID: 10843986
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity of ALK1 in pancreatic carcinoma cells.
Ungefroren H; Schniewind B; Groth S; Chen WB; Müerköster SS; Kalthoff H; Fändrich F
Int J Cancer; 2007 Apr; 120(8):1641-51. PubMed ID: 17230504
[TBL] [Abstract][Full Text] [Related]
37. Anti-TGF-beta antibody blocks enamel matrix derivative-induced upregulation of p21WAF1/cip1 and prevents its inhibition of human oral epithelial cell proliferation.
Kawase T; Okuda K; Yoshie H; Burns DM
J Periodontal Res; 2002 Aug; 37(4):255-62. PubMed ID: 12200968
[TBL] [Abstract][Full Text] [Related]
38. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
39. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression.
Hanafusa H; Ninomiya-Tsuji J; Masuyama N; Nishita M; Fujisawa J; Shibuya H; Matsumoto K; Nishida E
J Biol Chem; 1999 Sep; 274(38):27161-7. PubMed ID: 10480932
[TBL] [Abstract][Full Text] [Related]
40. Evidence for a role of MSK1 in transforming growth factor-beta-mediated responses through p38alpha and Smad signaling pathways.
Abécassis L; Rogier E; Vazquez A; Atfi A; Bourgeade MF
J Biol Chem; 2004 Jul; 279(29):30474-9. PubMed ID: 15133024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
